MindMaze Therapeutics to Present at Key Conferences

MindMaze Therapeutics Holding SA, a leader in precision neurotherapeutics, announced its participation in upcoming investor and industry conferences. These events will take place in the United States and Europe, showcasing the company's neurotechnology solutions.

Key investor conferences include the Baader Investment Conference in Munich on September 21, 2026, and the Global Markets Forum in New York on October 7, 2026. Management will be accessible for one-on-one meetings at these events.

On the industry front, MindMaze will present at the AMRPA Educational Conference in Austin from September 27-30, and at the ACRM Annual Fall Conference in Washington, D.C., on October 13-15. The company will also be part of the AAPM&R Annual Assembly in Orlando and the HLTH USA 2026 in Las Vegas.

MindMaze aims to highlight its real-world evidence and potentials to improve neurorehabilitation delivery. Presentation materials and replays will be available on their website.